Chris completed his BSc in Biomedical Science at the University of Cardiff in 2017, including one professional training year carried out the Centre for Neuropathology and Prion Research within Ludwig-Maximilians University of Munich. Within this time, he worked on generating stable reporter cell lines carrying Parkinson’s-associated mutations before returning to Cardiff for his final year involving a dissertation focused on bacterial alkaline phosphatase and its potential role in gut and liver inflammation.
Following this he then pursued an MSc in Molecular Biotechnology at the University of Barcelona, where he conducted a project focused on biofunctionalized hierarchical substrates for biomedical applications within the Institute of Materials Science of Barcelona.
Finally, in 2025 he completed his doctoral studies at the Institute of Bioengineering of Catalunya, where he focused on designing, fabricating, and validating biomaterials for cardiac regeneration. More specifically he utilised extensive experience in advanced cell culture techniques and molecular analysis to assess the impact on cardiac regeneration of a lactate-releasing nanocomposite, cardiac extracellular matrix hydrogels, and stem cell-derived secretome.
Within the ChemInFlow Group, Chris will be focused on experiment planning and running, along with analysing the results of cell studies and experiments focused on the biological impact of materials and systems built by the group.
